January 9, 2023 — RaySearch Laboratories AB announced that CGN Medical Technologies has in December 2002 placed an order for RayStation, which CGN has sold together with IBA’s proton therapy system to Yangzhou Hospital in China.
CGN Medical Technologies markets and sells IBA proton therapy systems in China. RayStation has been sold in combination with IBA’s proton therapy systems in China before, but the current order is the first one that RaySearch receives from CGN.
Particle treatment is a strongly growing market in China and treatment planning for particle treatments (protons/carbon ions/BNCT) is an important focus area for RaySearch. Today, RayStation is the market leader in this segment of cancer care, a position that is further strengthened by the new order.
Johan Löf, founder and CEO, RaySearch, says: “I am happy to announce our first order from CGN in China and look forward to a fruitful cooperation. Further, it is gratifying that RaySearch continues the long and global collaboration we have with IBA, together delivering proton therapy systems to centers all over the world.”
The order value is EUR 2,4 million (corresponding to approximately SEK 27 million) including five-year support contract. Revenue from the order will not be recognized in 2022.
For more information: www.raysearchlabs.com
September 29, 2026 
